DocGo (DCGO) Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DCGO shares.
View DCGO analyst ratings or view top-rated stocks.

2 equities research analysts have issued 12 month price objectives for DocGo's shares. Their DCGO share price forecasts range from $11.00 to $14.00. On average, they expect the company's share price to reach $12.50 in the next twelve months. This suggests a possible upside of 32.6% from the stock's current price.
View analysts price targets for DCGO or view top-rated stocks among Wall Street analysts.

DocGo's stock was trading at $7.07 at the beginning of the year. Since then, DCGO stock has increased by 33.4% and is now trading at $9.43.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our DCGO earnings forecast.

DocGo Inc. (NASDAQ:DCGO) issued its earnings results on Monday, March, 13th. The company reported $0.11 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.06. The firm had revenue of $108.79 million for the quarter, compared to the consensus estimate of $104.13 million. DocGo had a trailing twelve-month return on equity of 7.05% and a net margin of 4.70%. During the same quarter in the prior year, the company earned $0.17 earnings per share.

ETFs with the largest weight of DocGo (NASDAQ:DCGO) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Janus Henderson Small Cap Growth Alpha ETF (JSML), SPDR S&P Health Care Services ETF (XHS), Hartford Multifactor Small Cap ETF (ROSC), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Invesco Dynamic Market ETF (PWC) and iShares Micro-Cap ETF (IWC).iShares U.S. Healthcare Providers ETF (IHF).

DocGo updated its FY 2023 earnings guidance on Monday, May, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $500.00 million-$510.00 million, compared to the consensus revenue estimate of $504.42 million.

DocGo trades on the NASDAQ under the ticker symbol "DCGO."

DocGo's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.52%), Hood River Capital Management LLC (5.43%), Portolan Capital Management LLC (1.99%), Punch & Associates Investment Management Inc. (1.93%), State Street Corp (1.87%) and Emerald Advisers LLC (1.77%). Insiders that own company stock include Adriaan Stephanus Oberholzer and James M Travers.
View institutional ownership trends.

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DCGO stock can currently be purchased for approximately $9.43.

DocGo (NASDAQ:DCGO) has a market capitalization of $975.72 million and generates $440.52 million in revenue each year. The company earns $34.58 million in net income (profit) each year or $0.20 on an earnings per share basis.

The company employs 3,252 workers across the globe.

The official website for the company is www.docgo.com. The company can be reached via phone at 844-443-6246 or via email at ir@docgo.com.